Taiwan's Jyong Biotech to establish new manufacturing facility and US operations centre in Texas

Jyong Biotech, a Taiwan-based science-driven biotechnology company dedicated to the development and commercialisation of...

October 17, 2026 | Saturday | News
AtomVie inks strategic partnership with Jubilant Radiopharma to strengthen logistics and distribution in Clinical Trials

AtomVie Global Radiopharma, a global contract developer and manufacturer (CDMO) for radiopharmaceuticals, has announced ...

October 16, 2026 | Friday | News
Charles River collaborates with Magellan Stem Cells to advance regenerative medicine development

Charles River Laboratories International, Inc. and Magellan Stem Cells, a private Australian biotech and cell-therapy fi...

October 16, 2026 | Friday | News
China's Brii Biosciences unveils BRiSC™, an siRNA Therapeutics discovery platform

Brii Biosciences, a China-based biotechnology company developing therapies to improve patient health and choice across d...

October 16, 2026 | Friday | News
Japan's JCR Pharma receives marketing authorisation in Kuwait for Enzyme Replacement Therapy to treat Hunter Syndrome

Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...

October 15, 2026 | Thursday | News
Swiss firm Alentis Therapeutics partners with Korea's PinotBio to develop next-gen ADCs targeting claudin-1

Swiss firm Alentis Therapeutics and South Korea based PinotBio have entered into a research collaboration and licensing ...

October 15, 2026 | Thursday | News
New Sydney laboratory expands 360biolabs’ Australian network

360biolabs, a BioAgilytix company, has opened a new laboratory in Sydney, bringing its established bioanalytical experti...

October 15, 2026 | Thursday | News
Waters launches AI Link for advancing AI-enabled LC-MS workflows from research to release

US-based Waters Corporation has launched Waters AI Link, a software capability that brings Anthropic's Model Context Pro...

October 14, 2026 | Wednesday | News
Asieris Pharma partners with Theramex for global development of non-surgical treatment for cervical precancerous lesions in ANZ

Theramex, a London-headquartered specialty pharmaceutical company dedicated to women and their health, and China-based A...

October 13, 2026 | Tuesday | News
Roche inks $1.06 B deal with China's Rona Therapeutics for RNA-based metabolic therapies

Chinese startup Rona Therapeutics has granted Roche an exclusive worldwide license for Rona's investigational RNAi candi...

October 14, 2026 | Wednesday | News
Korea's NTL HEALTHCARE announces global launch of On-Premises AI Solution 'CerviCARE® AI AT'

South Korea-based NTL HEALTHCARE, a women's health AI company, has announced the global launch of CerviCARE® AI AT, ...

October 16, 2026 | Friday | News
Americhem opens new clean compounding facility in Suzhou, China

Americhem, a global leader in custom polymer solutions, recently celebrated the opening of its new clean compounding fac...

October 13, 2026 | Tuesday | News
ITOCHU Corp signs capital alliance agreement with MOLCURE Inc. for AI-based drug discovery in Japan

ITOCHU Corporation has signed a capital alliance agreement with MOLCURE Inc., which possesses AI-driven drug discovery t...

October 14, 2026 | Wednesday | News
Australia's Firebrick Pharma secures $732k in strategic investments

Australia-based Firebrick Pharma has secured firm commitments from strategic investors for approximately $732k, through ...

October 12, 2026 | Monday | News
Ono Pharma inks $100 M agreement with Biohaven to develop and commercialise IgG degraders in Japan, South Korea, Taiwan, and ASEAN countries

Japan-based Ono Pharmaceutical has entered into an exclusive license agreement with Biohaven, together with its wholly o...

October 12, 2026 | Monday | News
Korea's Lunit collaborates with US-based Discovery Life Sciences to expand AI-powered tissue analysis for biopharma research

South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced a strateg...

October 12, 2026 | Monday | News
Foresee Pharma announces China NMPA approval of CAMCEVI® 42 mg for treatment of advanced prostate cancer

Taiwan-based Foresee Pharmaceuticals has been notified by its licensing partner, Changchun GeneScience Pharmaceutical (G...

October 12, 2026 | Monday | News
Japan's Shimadzu initiates validation of mass spec solution for core labs in Australia

Japan-based Shimadzu Corporation has started the development and validation of a mass spectrometry (MS) solution for cor...

October 9, 2026 | Friday | News
Danaher accelerates Life Sciences research with new AI-powered autonomous lab

US-based Danaher Corporation has announced plans to launch its first AI-powered autonomous lab, designed to help researc...

October 9, 2026 | Friday | News
Korea's LOTTE Biologics inks US-based manufacturing agreement with Alvotech to increase global supply

South Korea-based LOTTE Biologics, a contract development and manufacturing (CDMO) organisation, and Alvotech, a global ...

October 9, 2026 | Friday | News
GE HealthCare buys SOFIE Biosciences for $945 M to establish 'Final Mile' footprint for PET Radiopharmaceutical Supply in US

GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopha...

October 8, 2026 | Thursday | News
China's XtalPi debuts Kodexia™ as world's first closed-loop siRNA platform

China's XtalPi Holdings, an AI and robotics-driven drug and materials discovery company, has debuted Kodexia™, the...

October 8, 2026 | Thursday | News
Korea's GC Cell and Israel-based QuantHealth collaborate to optimise clinical cevelopment of cell therapy product

South Korea-based GC Cell, a leader in the cell and gene therapy (CGT) sector within the biopharmaceutical industry, and...

October 8, 2026 | Thursday | News
Japan's Shionogi continues rare disease expansion with acquisition of IntraBio for $2 B

Japan-based Shionogi & Co. is entering into an agreement to acquire IntraBio Inc, a biopharmaceutical company develo...

October 8, 2026 | Thursday | News
AstraZeneca opens new global strategic R&D centre in Massachusetts, US

AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kenda...

October 7, 2026 | Wednesday | News